Adenotonsillar disease.
Adenotonsillar disease can be divided into two categories, infection and hypertrophy. They are closely related with low grade infection causing hypertrophy in most instances. Minor advances have been accomplished in the treatment of infectious processes, mainly the advent of new antibiotics. More important advances have occurred in the field of airway obstruction secondary to adenotonsillar hypertrophy. Currently there exists a significant body of knowledge on obstructive sleep apnea. With improvement in anesthetic and surgical techniques younger children are being treated earlier to relief airway obstruction. This manuscript describes current management of adenotonsillar disease.
Zalzal
G H
GH
George Washington University, Washington D.C., USA.
D000233:Adenoidectomy; D000234:Adenoids / Q000473:pathology*; D000402:Airway Obstruction / Q000209:etiology / Q000628:therapy; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D006801:Humans; D006984:Hypertrophy; D008199:Lymphadenitis / Q000382:microbiology / Q000821:virology; D014066:Palatine Tonsil / Q000473:pathology*; D012891:Sleep Apnea Syndromes / Q000209:etiology / Q000628:therapy; D014068:Tonsillectomy; D014069:Tonsillitis / Q000382:microbiology / Q000821:virology
D000900:Anti-Bacterial Agents